FDA approves leucovorin as the first treatment for FOLR1-related cerebral folate deficiency, while evidence remains insufficient for autism treatment.
Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results